These data suggest that TRX protects from stress‐induced ferroptosis via inhibition of p53 induction, and that the differential proliferative/protective effects of ORP100S and rhTRX may result from selective inability of ORP100S to down‐regulate expression of p53 at the transcriptional level in cancer cells. This evidence concerns the gene TXN and cancer.